[Simultaneous application of a beta-adrenergic sympathicomimetic and beta-adrenergic antagonist during inhibition of labor (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D002082:Butylamines / Q000008:administration & dosage / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D009921:Metaproterenol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009119:Muscle Contraction / Q000187:drug effects; D009570:Nitriles / Q000008:administration & dosage / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011412:Propanolamines / Q000008:administration & dosage* / Q000627:therapeutic use; D013566:Sympathomimetics / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D014599:Uterus / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D002082:Butylamines; D009570:Nitriles; D010636:Phenols; D011412:Propanolamines; D013566:Sympathomimetics; D009921:Metaproterenol
Gleichzeitige Anwendung einer beta-mimetischen und beta-rezeptorenblockierenden Substanz bei der Wehenhemmung